Suchergebnisse - "Lervat, Cyril"

PubPharm (10)

1

Late toxicity comparison of alkylating-based maintenance regimen with cyclophosphamide (VAC) vs ifosfamide (VAI) in Ewing sarcoma survivors treated in the randomized clinical trial Euro-EWING99-R1 in France

enthalten in: International journal of cancer | 2023

von Corvest, V. | Marec-Bérard, P. | Lervat, C. | +25

2

Immune Infiltrate and Tumor Microenvironment Transcriptional Programs Stratify Pediatric Osteosarcoma into Prognostic Groups at Diagnosis

enthalten in: Cancer research | 2022

von Marchais, A. | Marques da Costa, M. | Job, B. | +21

3

Lenvatinib with etoposide plus ifosfamide in patients with refractory or relapsed osteosarcoma (ITCC-050) : a multicentre, open-label, multicohort, phase 1/2 study

enthalten in: The Lancet. Oncology | 2021

von Gaspar, N. | Venkatramani, R. | Hecker-Nolting, S. | +19

CommentIn: Lancet Oncol. 2021 Sep;22(9):1206-1207. - PMID 34416160

4

Methotrexate-Etoposide-Ifosfamide Compared with Doxorubicin-Cisplatin-Ifosfamide Chemotherapy in Osteosarcoma Treatment, Patients Aged 18-25 Years

enthalten in: Journal of adolescent and young adult oncology | 2020

von Marec-Berard, P. | Laurence, V. | Occean, B. | +17

5

Cabozantinib in patients with advanced Ewing sarcoma or osteosarcoma (CABONE) : a multicentre, single-arm, phase 2 trial

enthalten in: The Lancet. Oncology | 2020

von Italiano, A. | Mir, O. | Mathoulin-Pelissier, S. | +19

CommentIn: Lancet Oncol. 2020 Mar;21(3):331-332. - PMID 32078814

6

A multicentric randomized phase II clinical trial evaluating high-dose thiotepa as adjuvant treatment to standard chemotherapy in patients with resectable relapsed osteosarcoma

enthalten in: European journal of cancer (Oxford, England : 1990) | 2020

von Marec-Berard, P. | Dalban, C. | Gaspar, N. | +13

7

High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases : Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2019

von Dirksen, U. | Brennan, B. | Le Deley, M. | +40

CommentIn: J Clin Oncol. 2019 Dec 1;37(34):3173-3175. - PMID 31634031

8

A Pharmacokinetic and Pharmacogenetic Analysis of Osteosarcoma Patients Treated With High-Dose Methotrexate : Data From the OS2006/Sarcoma-09 Trial

enthalten in: Journal of clinical pharmacology | 2018

von Lui, G. | Treluyer, J. | Fresneau, B. | +19

9

Results of methotrexate-etoposide-ifosfamide based regimen (M-EI) in osteosarcoma patients included in the French OS2006/sarcome-09 study

enthalten in: European journal of cancer (Oxford, England : 1990) | 2018

von Gaspar, N. | Occean, B. | Pacquement, H. | +24

10

Off-label use of targeted therapies in osteosarcomas : data from the French registry OUTC'S (Observatoire de l'Utilisation des Thérapies Ciblées dans les Sarcomes)

enthalten in: BMC cancer | 2015

von Penel-Page, M. | Ray-Coquard, I. | Larcade, J. | +18

1
[1]